Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Louisiana Senator Poised To Oppose HHS Nominee Burwell’s Confirmation

This article was originally published in The Gray Sheet

Executive Summary

Sylvia Mathews Burwell has up until now received widespread support on Capitol Hill to take over HHS, but Sen. David Vitter, R-La., Monday indicated he plans to oppose her nomination.

You may also be interested in...



Burwell Sails Through Senate Finance Panel Confirmation

Sylvia Mathews Burwell was easily confirmed by the Senate Finance Committee May 21 to be HHS Secretary.

HHS Appointee Burwell Tells Senate Panel IPAB Will ‘Never Be Activated’

HHS Secretary nominee Sylvia Mathews Burwell told Senate HELP Committee members at her May 8 nomination hearing that the Independent Payment Advisory Board required by the Affordable Care Act will likely “never be activated” because the Obama administration has been able to lower health care costs.

Long Hot Summer For Novel Drug Reviews Forecast At US FDA

Submission surge in late 2019 means a spike in late summer 2020 user fee goals, including 16 novel agents in August alone.

Topics

UsernamePublicRestriction

Register

MT033027

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel